Experimental Medicine and Therapy Research

Fields of research

  • Analysis of minimal residual disease of cancer patients
  • Development of techniques for molecular genetic analysis of single cells
  • Development of strategies for personalized medicine
  • Tumorbiology: Spreading of tumor cells and development of metastases/ Biology of normal and maligne stem cells
  • Diagnosis: of minimal residual disease/ disseminated tumour cells in bone marrow/ blood and lymph nodes of tumor patients/ of the HER2- gene amplification/ of KRAS-, BRAF-, NRAS- mutations in single diesseminated cells

Research projects

  • Frauenhofer projectgroup „personalized tumor therapy“
  • Identification of genetic modifications which induce cancer- and metastases
  • Development of new therapies (ECR-Advanced grant)
  • Research group 2127 „„Selection and adaption during metastatic cancer progression“

Co-operations

  • German Cancer Aid
  • BayGene
  • Federal Ministry of Education and Research (BioFuture)
  • Fraunhofer Institute for Toxicology and Experimental Medicine  (Fraunhofer-ITEM)
  • European Research Council (erc)
  • Prostate cancer foundation
  • Fritz Thyssen Stiftung für Wissenschaftsförderung
  • Friedrich-Baur-Stiftung
  • Migrating Cancer Stem Cells (MDSCs)

Go back